StockNews.com upgraded shares of Kewaunee Scientific (NASDAQ:KEQU – Free Report) from a buy rating to a strong-buy rating in a report published on Saturday.
Kewaunee Scientific Stock Performance
Shares of KEQU opened at $49.97 on Friday. The firm has a market capitalization of $141.91 million, a P/E ratio of 7.87 and a beta of 0.77. Kewaunee Scientific has a 52 week low of $15.25 and a 52 week high of $55.62. The stock has a 50 day moving average price of $46.28 and a two-hundred day moving average price of $38.52. The company has a debt-to-equity ratio of 0.61, a quick ratio of 1.76 and a current ratio of 2.28.
Kewaunee Scientific (NASDAQ:KEQU – Get Free Report) last announced its quarterly earnings results on Wednesday, June 26th. The technology company reported $1.55 earnings per share (EPS) for the quarter. Kewaunee Scientific had a return on equity of 28.58% and a net margin of 9.20%. The business had revenue of $56.70 million during the quarter.
Institutional Inflows and Outflows
About Kewaunee Scientific
Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.
Featured Articles
- Five stocks we like better than Kewaunee Scientific
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Moderna Dips on Q2 Earnings But Can It Rip on a Short Squeeze?
- Why Are Stock Sectors Important to Successful Investing?
- 2 Option Strategies to Maximize Profits in a Bear Market
- The How And Why of Investing in Oil Stocks
- Lululemon Stock Gears Up for a Massive Comeback Rally
Receive News & Ratings for Kewaunee Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kewaunee Scientific and related companies with MarketBeat.com's FREE daily email newsletter.